Matthew Shinkle

The FDA approved belzutifan in combination with lenvatinib for adults with advanced renal cell carcinoma with a clear cell component following treatment with a PD-1 or PD-L1 inhibitor.

Approximately one in four adults with hepatitis C virus infection who initiated treatment with direct-acting antivirals did not undergo follow-up RNA testing, according to a research letter published in JAMA Network Open

NASHVILLE, Tenn. — A mailed fecal immunochemical test-based outreach program increased colorectal cancer screening rates by more than 50% among underserved adults in New York City, according to study results.

NASHVILLE, Tenn. — Two doses of hepatitis B virus vaccine with CpG adjuvant may not be sufficient for people with HIV who do not respond to an

NASHVILLE, Tenn. — Gastroenterologists in rural areas performed 37% more general endoscopies per physician than their urban peers, but 14% fewer

NASHVILLE, Tenn. — Patients with Crohn's disease achieved significantly higher clinical remission and endoscopic response rates at week 12 with subcutaneous risankizumab induction than with placebo, study results showed.

NASHVILLE, Tenn. — Patients with primary sclerosing cholangitis and moderate to severe pruritus reported significantly lower cholestatic pruritus and sleep disturbance with volixibat than with placebo, VISTAS trial data showed.

NASHVILLE, Tenn. — Two machine learning models demonstrated high accuracy in identifying adenomas and sessile serrated lesions, although more research

The FDA has expanded its approval of Skyrizi to include subcutaneous induction for adults with moderately to severely active Crohn's disease.

NASHVILLE, Tenn. — Medicaid expansion did not appear to reduce inflammatory bowel disease-specific mortality over a 26-year period, according to a presenter at ACG Annual Scientific Meeting.